GLYLO Supplement Pilot Trial on Glycation and Aging in Postmenopausal Women

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 1, 2025

Primary Completion Date

April 30, 2026

Study Completion Date

June 30, 2026

Conditions
PostmenopauseMetabolismGeroscience
Interventions
OTHER

GLYLO

"commercially available combination of glycation-lowering compounds that are GRAS (generally recognized as safe) by the FDA.~GLYLO Ingredients Benfotiamine (fat-soluble Vitamin B1 derivative)-100mg Vitamin B6 (Pyridoxine Hydrochloride)-50mg Nicotinamide-200mg Alpha Lipoic Acid-150mg Piperine-10mg~For the first week, one GLYLO capsule daily, 5 minutes after the first meal. From week 2 onwards, two capsules of GLYLO daily, one capsule after the first meal and a second capsule after the last meal."

OTHER

Placebo

"Visually matched capsule with microcrystalline cellulose as an inert ingredient.~For the first week, one placebo capsule daily, 5 minutes after the first meal. From week 2 onwards, two capsules of the placebo daily, one capsule after the first meal and a second capsule after the last meal."

Trial Locations (1)

94945

RECRUITING

The Buck Institute for Research on Aging, Novato

All Listed Sponsors
lead

Buck Institute for Research on Aging

OTHER